Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on May 03, 2024 - 12:06PM >>   ABB 6712.35 [ 0.49 ]ACC 2516 [ -0.47 ]AMBUJA CEM 620.65 [ -0.76 ]ASIAN PAINTS 2929.65 [ -1.48 ]AXIS BANK 1144.35 [ -0.47 ]BAJAJ AUTO 9175 [ 0.78 ]BANKOFBARODA 276.85 [ -0.88 ]BHARTI AIRTE 1280.55 [ -1.96 ]BHEL 312.65 [ 6.83 ]BPCL 628.6 [ -0.98 ]BRITANIAINDS 4718.5 [ -0.88 ]CIPLA 1422.6 [ 0.21 ]COAL INDIA 462.6 [ 2.06 ]COLGATEPALMO 2791.95 [ -0.69 ]DABUR INDIA 526.15 [ 0.35 ]DLF 874.35 [ -2.39 ]DRREDDYSLAB 6340.6 [ 0.83 ]GAIL 202.4 [ -1.27 ]GRASIM INDS 2474 [ 1.63 ]HCLTECHNOLOG 1341.5 [ -1.39 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1522.25 [ -0.70 ]HEROMOTOCORP 4542.5 [ -0.44 ]HIND.UNILEV 2211.5 [ -0.63 ]HINDALCO 644 [ 0.41 ]ICICI BANK 1142.6 [ 0.24 ]IDFC 119.6 [ -1.44 ]INDIANHOTELS 569.6 [ -1.10 ]INDUSINDBANK 1486.35 [ -1.29 ]INFOSYS 1411.85 [ -0.21 ]ITC LTD 435.2 [ -0.89 ]JINDALSTLPOW 936.05 [ -0.62 ]KOTAK BANK 1560 [ -1.00 ]L&T 3533.4 [ -1.78 ]LUPIN 1657.3 [ 0.58 ]MAH&MAH 2180.45 [ -0.18 ]MARUTI SUZUK 12584.65 [ -1.63 ]MTNL 37.82 [ -0.58 ]NESTLE 2464.05 [ -1.88 ]NIIT 104.65 [ -0.57 ]NMDC 263.15 [ 1.82 ]NTPC 366.95 [ -0.65 ]ONGC 287.4 [ 1.68 ]PNB 135.75 [ -1.63 ]POWER GRID 311.55 [ -0.61 ]RIL 2871.5 [ -2.07 ]SBI 822.1 [ -0.96 ]SESA GOA 411.65 [ 0.23 ]SHIPPINGCORP 221.7 [ -2.57 ]SUNPHRMINDS 1509.15 [ -0.61 ]TATA CHEM 1087.7 [ -1.18 ]TATA GLOBAL 1103.25 [ 1.11 ]TATA MOTORS 1014.9 [ -1.27 ]TATA STEEL 167.3 [ -0.03 ]TATAPOWERCOM 454.8 [ -0.63 ]TCS 3809.1 [ -1.41 ]TECH MAHINDR 1254.45 [ -0.98 ]ULTRATECHCEM 9915.75 [ -0.66 ]UNITED SPIRI 1185.6 [ -0.73 ]WIPRO 454.65 [ -0.57 ]ZEETELEFILMS 141.55 [ -1.63 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 532872ISIN: INE232I01014INDUSTRY: Medical Research Services

BSE   ` 229.45   Open: 239.35   Today's Range 227.25
239.40
-8.00 ( -3.49 %) Prev Close: 237.45 52 Week Range 178.10
474.00
Year End :2023-03 

Sun Pharma Advanced Research Company Limited Report on the Audit of the Financial Statements

Opinion

We have audited the accompanying financial statements of Sun Pharma Advanced Research Company Limited (the "Company"), which comprise the Balance Sheet as at March 31, 2023, the Statement of Profit and Loss, including the Statement of Other Comprehensive Income, the Statement of Cash Flows and the Statement of Changes in Equity for the year then ended, and notes to the financial statements, including a summary of significant accounting policies and other explanatory information.

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid financial statements give the information required by the Companies Act, 2013, as amended (the "Act") in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2023, its loss including other comprehensive income, its cash flows and the changes in equity for the year ended on that date.

Basis for Opinion

We conducted our audit of the financial statements in accordance with the Standards on Auditing (SAs), as specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the Financial Statements' section of our report. We are independent of the Company in accordance with the 'Code of Ethics' issued by the Institute of Chartered Accountants of India

together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements for the financial year ended March 31, 2023. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. For each key audit matter below, our description of how our audit addressed the matter is provided in that context.

We have determined the matters described below to be the key audit matters to be communicated in our report. We have fulfilled the responsibilities described in the Auditor's responsibilities for the audit of the financial statements section of our report, including in relation to these matters. Accordingly, our audit included the performance of procedures designed to respond to our assessment of the risks of material misstatement of the financial statements. The results of our audit procedures, including the procedures performed to address the matters below, provide the basis for our audit opinion on the accompanying financial statements.

Key audit matters

How our audit addressed the key audit matter

(a) Revenue recognition (as described in Note 27 of the financial statements)

The Company is engaged in the business of Research and

Our audit procedures amongst others included the following:

Development of pharmaceutical products. The Company has various contractual arrangements with customers which are entered into at various stages of research and development. The Company, in line with Ind AS 115

• Read the accounting policy for revenue recognition of the Company and assessed compliance with the principles enunciated under Ind AS 115.

recognises revenue based on the contractual terms and

• Evaluated the design and tested the operating effectiveness of

performance obligations with customers. Some of these

management's controls in respect of revenue recognition.

arrangements involve judgments which may impact the

• Obtained a sample of contracts and reviewed the terms of

manner and timing of revenue recognition.

the arrangements to determine whether the work performed

Considering that contractual arrangements with customers

under the contract qualified for revenue recognition having

involve judgments which may impact the manner and

regard to the performance obligations under the contracts.

timing of revenue recognition, accordingly it is considered

• Assessed the disclosures in the accompanying financial

as a key audit matter.

statements.

Evaluation of direct tax and indirect tax litigations (as described in Note 42 of the financial statements)

The Company has material direct tax and indirect tax

Our audit procedures amongst others included the following:

litigations which involve significant judgment to determine

• Evaluated the design and tested the operating effectiveness

the possible outcome of these disputes and accordingly it is considered as key audit matter.

of controls in respect of the identification and evaluation of tax litigations and the recording and reassessment of the related liabilities and provisions and disclosures.

• Obtained list of ongoing tax litigations from management along with their assessment of the cases based on past precedents, judgements and matters in the jurisdiction, legal opinions sought by management, correspondences with tax department etc.

• Engaged tax specialists, to evaluate management's assessment of the outcome of these litigations. Our specialists considered legal precedence and other rulings in evaluating management's position on these tax litigations.

• Assessed contingent liability disclosure in the accompanying financial statements.


Other Information

The Company's Board of Directors is responsible for the other information. The other information comprises the information included in the Management Discussion and Analysis Report, Business Responsibility and Sustainability Report and Board's Report, but does not include the financial statements and our auditor's report thereon. The Management Discussion and Analysis Report, Business Responsibility and Sustainability Report and Board's Report is expected to be made available to us after the date of this auditor's report.

Our opinion on the financial statements does not cover the other information and we will not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information identified above

when it becomes available and, in doing so, consider whether such other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated

Responsibilities of Management for the Financial Statements

The Company's Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash flows and changes in equity of the Company in accordance with the accounting principles generally accepted in India, including the Indian Accounting Standards (Ind AS) specified under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015,

as amended. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Those Board of Directors are also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

• Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements for the financial year ended March 31, 2023 and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.


Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's Report) Order,

2020 ("the Order"), issued by the Central Government of

India in terms of sub-section (11) of section 143 of the Act, we

give in the "Annexure 1" a statement on the matters specified

in paragraphs 3 and 4 of the Order.

2. As required by Section 143(3) of the Act, we report that:

(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit;

(b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books;

(c) The Balance Sheet, the Statement of Profit and Loss including the Statement of Other Comprehensive Income, the Statement of Cash Flows and Statement of Changes in Equity dealt with by this Report are in agreement with the books of account;

(d) In our opinion, the aforesaid financial statements comply with the Accounting Standards specified under Section 133 of the Act, read with Companies (Indian Accounting Standards) Rules, 2015, as amended;

(e) On the basis of written representations received from the directors as on March 31, 2023 taken on record by the Board of Directors, none of the directors is disqualified as on March 31, 2023 from being appointed as a director in terms of Section 164 (2) of the Act;

(f) With respect to the adequacy of the internal financial controls with reference to these financial statements and the operating effectiveness of such controls, refer to our separate Report in "Annexure 2" to this report;

(g) Based on the information and explanations provided to us and based on our examination of books of accounts, the Company has not accrued / paid any managerial remuneration to its directors. Accordingly, the provision of section 197 read with Schedule V to the Act are not required to be complied with;

(h) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its financial statements - Refer Note 42 to the financial statements;

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses;

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company.

iv. a) The management has represented that, to the

best of its knowledge and belief, and read with Note 48 to the financial statements, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities ("Intermediaries"), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries;

b) The management has represented that, to the best of its knowledge and belief, and read with Note 48 to the financial statements, no funds have been received by the Company from any person(s) or entity(ies), including foreign entities ("Funding Parties"), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether, directly or indirectly, lend or invest in other

persons or entities identified in any manner whatsoever by or on behalf of the Funding Party ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries; and

c) Based on such audit procedures performed that were considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under sub-clause (a) and (b) contain any material misstatement.

v. No dividend has been declared or paid during the year by the Company.

vi. As proviso to Rule 3(1) of the Companies (Accounts) Rules, 2014 is applicable for the Company only w.e.f. April 1, 2023, reporting under this clause is not applicable.

For S R B C & CO LLP

Chartered Accountants ICAI Firm Registration Number: 324982E/E300003

per Amit Singh

Partner

Place of Signature: Mumbai Membership Number: 408869 Date: May 22, 2023 UDIN: 23408869BGXKKA8070